Johnson & Johnson (JNJ) Financials — Income, Balance Sheet & Cash Flow | Market Terminal

Market Terminal

Get Full Access To
Market Terminal For Free

Real-time breakouts. AI-powered analysis. The terminal that levels the playing field.

Open Terminal

BreakoutsScreenerAI AnalysisCalendarsMarketsNewsletters

Market Terminal

Get Full Access To
Market Terminal For Free

Real-time breakouts. AI-powered analysis. The terminal that levels the playing field.

Open Terminal

BreakoutsScreenerAI AnalysisCalendarsMarketsNewsletters

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand.

Get Full Access To Market Terminal For Free

Get Full Access To Market Terminal For Free

Johnson & Johnson (JNJ)

Explore More Tools

Get Full Access To
Market Terminal For Free

Get Full Access To
Market Terminal For Free